Accendra Health, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Accendra Health, Inc. (ACH) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value of $19.50 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue · last filed 2026-02-20
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2025-09-30 was $14.69, a 29.51% decline year-over-year.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2025-06-30 was $14.57, a 32.64% decline year-over-year.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2024-09-30 was $20.84.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2024-06-30 was $21.63.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2025 was $19.50, a 8.24% decline from fiscal 2024.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2024 was $21.25, a 20.77% decline from fiscal 2023.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2023 was $26.82, a 138.40% increase from fiscal 2022.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2022 was $11.25, a 84.43% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $19.50 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | $14.69 10-Q · filed 2025-10-31 | $23.68 10-Q · filed 2025-10-31 | |||
| 2025-06-30 | $14.57 10-Q · filed 2025-08-11 | $25.80 10-Q · filed 2025-08-11 | |||
| 2024-12-31 | $21.25 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | $20.84 10-Q · filed 2025-10-31 | $21.25 10-Q · filed 2025-10-31 | |||
| 2024-06-30 | $21.63 10-Q · filed 2025-08-11 | $21.41 10-Q · filed 2025-08-11 | |||
| 2023-12-31 | $26.82 10-K · filed 2026-02-20 | ||||
| 2022-12-31 | $11.25 10-K · filed 2025-02-28 | $11250.00 10-K · filed 2023-02-28 | |||
| 2021-12-31 | $6.10 10-K · filed 2024-02-20 | ||||
| 2020-12-31 | $7690.00 10-K · filed 2023-02-28 | $7.69 10-K · filed 2021-02-24 | |||
| 2019-12-31 | $11.86 10-K · filed 2022-02-23 | ||||
| 2018-12-31 | $22.59 10-K · filed 2020-03-04 | ||||
| 2017-12-31 | $34.49 10-K · filed 2019-03-06 | ||||
| 2016-12-31 | $34.06 10-K · filed 2019-03-06 | ||||
| 2015-12-31 | $33.27 10-K · filed 2018-02-23 | ||||
| 2014-12-31 | $30.89 10-K · filed 2017-02-17 | ||||
| 2013-12-31 | $30.51 10-K · filed 2016-02-25 | ||||
| 2012-12-31 | $30.35 10-K · filed 2015-02-23 | ||||
| 2011-12-31 | $28.43 10-K · filed 2014-02-25 | ||||
| 2010-12-31 | $23.50 10-K · filed 2013-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HENRY SCHEIN INC (HSIC) | United States | $9.536B | 23.59 |